Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares changing hands.
Eisai Trading Down 2.1%
The firm has a market capitalization of $17.64 billion, a price-to-earnings ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.77 and a current ratio of 2.20. The company has a 50 day moving average price of $61.51 and a two-hundred day moving average price of $61.51.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Further Reading
- Five stocks we like better than Eisai
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
